Unrelated DonorsHematopoietic Stem Cell TransplantationBone Marrow TransplantationGraft vs Host DiseaseHistocompatibility TestingTransplantation, HomologousTransplantation ConditioningHematopoietic Stem CellsPeripheral Blood Stem Cell TransplantationTransplantation, AutologousStem Cell TransplantationBone MarrowTissue DonorsHematologic NeoplasmsBone Marrow CellsTransplantation ChimeraHistocompatibilityWhole-Body IrradiationStem CellsGraft SurvivalHematopoietic Stem Cell MobilizationBusulfanLeukemiaTreatment OutcomeCord Blood Stem Cell TransplantationRecurrenceHematopoiesisAnemia, AplasticAntigens, CD34Granulocyte Colony-Stimulating FactorCombined Modality TherapyLiver TransplantationCyclophosphamideMyeloablative AgonistsRetrospective StudiesImmunosuppressive AgentsRemission InductionHLA AntigensLeukemia, Myeloid, AcuteTransplantation, IsogeneicMelphalanGraft vs Leukemia EffectTime FactorsHematologic DiseasesSurvival AnalysisMultiple MyelomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukapheresisPrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic SyndromesTransplantation ImmunologySurvival RateDisease-Free SurvivalKidney TransplantationHepatic Veno-Occlusive DiseaseLymphocyte DepletionT-LymphocytesChimerismVidarabineMice, Inbred C57BLAntineoplastic Combined Chemotherapy ProtocolsGraft vs Tumor EffectLymphoma, Non-HodgkinAcute DiseaseBone Marrow PurgingCell DifferentiationFlow CytometryGraft RejectionSiblingsBone and BonesAntilymphocyte SerumColony-Forming Units AssayLymphocyte TransfusionSevere Combined ImmunodeficiencyImmunosuppressionCytomegalovirus InfectionsBlood DonorsFollow-Up StudiesLiving DonorsLeukemia, MyeloidBone Marrow DiseasesBlood Component RemovalFetal BloodSalvage TherapyBlood CellsCells, CulturedMesenchymal Stem Cell TransplantationCell TransplantationCyclosporineInfectionCell LineageBlood Cell CountCytarabineCell SeparationDonor SelectionEtoposideRadiation ChimeraHeart TransplantationLeukocyte TransfusionLymphoma